Riskpilot← Back to searchSign inGet full accessBjörklund Consulting AB
ABActiveOrg 5568373152Linnégatan 10 DOther business support service activities n.e.c. · NACE 8299Est. 20110 employees
Revenue 2024
SEK 0
EBITDA margin
—
-179% vs 2023
Equity ratio
79.2%
Financial strength
Net profit 2024
SEK 8K
-75% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -25K | -179% |
| Net profit | SEK 8K | -75% |
| Total assets | SEK 1,3M | -14% |
| Equity | SEK 1M | -16% |
| Employees | 0 | — |
Legal name
Björklund Consulting AB
Org number
5568373152
Legal form
Aktiebolag
NACE code
8299 · Other business support service activities n.e.c.
Founded
7 januari 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva verksamhet inom forskning, utveckling rådgivning, undervisning, utvärdering och förtroendeuppdrag inom det medicinska området och därmed förenlig verksamhet. Bolaget skall även direkt eller indirekt via bolag äga och förvalta aktier och värdepapper samt därmed förenlig verksamhet.
Address
Linnégatan 10 D
Email
dr.tomas.bjorklund@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 126 | 14 | 0 | 78 | 0 |
| Staff expenses | — | — | −1 | −1 | −0 |
| EBITDA | 1 056 | −6 | −37 | 32 | −25 |
| Depreciation & amort. | −0 | −1 | −1 | −1 | −1 |
| EBIT | 1 056 | −7 | −38 | 31 | −26 |
| Net financials | — | — | 215 | 25 | 20 |
| Profit before tax | 791 | −2 | 209 | 41 | 14 |
| Tax | −169 | −0 | — | −9 | −6 |
| Net profit | 622 | −2 | 209 | 32 | 8 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 970 | 1 683 | 1 646 | 1 510 | 1 303 |
| Equity | 1 572 | 1 370 | 1 391 | 1 228 | 1 031 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 95 | 15 | −11 | 2 | 11 |
| Total debt | 95 | 15 | −11 | 2 | 11 |
EBITDA margin
-2540900.0%
This company
15.8%
Market median
-16081746% vs market
20202024
Equity ratio
79.2%
This company
38.2%
Market median
+107% vs market
20202024
Return on equity
0.8%
This company
18.4%
Market median
-96% vs market
20202024
Net profit margin
802800.0%
This company
8.1%
Market median
+9911011% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Björklund Consulting AB 
Brave Bioscience ABBoard members of Björklund Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Margaretha Björklund | Deputy Board Member | 0 companies |
| Tomas Olof Axel Björklund | Chairman | 0 companies |
| Anders Olov Hjalmar Björklund | Deputy Board Member | 0 companies |
| Emma Caroline Suzanne Björklund | Board of Directors | 0 companies |